新华医疗(600587) - 2020 Q1 - 季度财报

Financial Performance - Operating revenue for the first quarter was approximately CNY 1.73 billion, down 14.66% year-on-year[11]. - Net profit attributable to shareholders was approximately CNY 33.40 million, a significant decrease of 94.06% compared to the same period last year[11]. - Basic earnings per share were CNY 0.08, down 94.20% from CNY 1.38 in the same period last year[11]. - The weighted average return on equity decreased by 12.75 percentage points to 0.80%[11]. - The total comprehensive income for Q1 2020 was ¥29,693,101.56, down from ¥571,237,833.94 in Q1 2019, a decline of 94.8%[44]. - Net profit for Q1 2020 was ¥30,347,755.56, a significant decline from ¥570,589,875.37 in Q1 2019, representing a decrease of 94.7%[42]. - The total profit for Q1 2020 was ¥31.03 million, down from ¥72.56 million in Q1 2019, representing a decline of approximately 57.3%[48]. Cash Flow - Net cash flow from operating activities was negative CNY 973,860.32, a decline of 100.95% compared to the previous year[11]. - The company reported a net cash outflow from operating activities of ¥973,860.32 in Q1 2020, contrasting with a net inflow of ¥102.66 million in Q1 2019[50]. - Operating cash inflow totaled ¥739.52 million, an increase from ¥608.36 million year-over-year[55]. - Net cash flow from operating activities reached ¥147.91 million, a significant improvement from a negative ¥66.74 million in the previous year[55]. - Cash inflow from investment activities was ¥20.62 million, down from ¥54 million year-over-year[55]. - Cash outflow for investment activities was ¥29.93 million, compared to ¥86.96 million in the previous year[55]. - Cash inflow from financing activities was ¥547.50 million, a decrease from ¥1.20 billion year-over-year[55]. - Cash outflow for debt repayment was ¥600.06 million, down from ¥1.17 billion[55]. Assets and Liabilities - Total assets at the end of the reporting period were approximately CNY 11.57 billion, a decrease of 0.36% compared to the end of the previous year[11]. - Total liabilities decreased from CNY 6,915,055,643.37 to CNY 6,857,787,604.70, a decline of about 0.83%[35]. - The company reported a total asset value of approximately ¥11.61 billion, with current assets totaling about ¥2.97 billion[67]. - The total current liabilities reached approximately ¥4.23 billion, while non-current liabilities were about ¥452.33 million[70]. - The company's retained earnings stood at approximately ¥2.01 billion, contributing to total equity attributable to shareholders of about ¥4.18 billion[64]. - The company’s long-term investments amounted to approximately ¥2.80 billion, reflecting its commitment to growth[67]. Shareholder Information - The total number of shareholders at the end of the reporting period was 41,909[16]. - The largest shareholder, Zibo Mining Group Co., Ltd., held 28.77% of the shares[16]. - Shareholders' equity increased from CNY 4,692,854,984.03 to CNY 4,708,702,864.53, an increase of approximately 0.34%[35]. - Shareholders' equity totaled ¥2,937,971,021.88 in Q1 2020, up from ¥2,911,961,582.38 in Q1 2019, indicating an increase of 0.9%[40]. Changes in Accounting Policies - The company's prepayments decreased by 100% due to changes in accounting policies, with a balance of RMB 1,126,757,847.13 at the beginning of the year[22]. - Contract liabilities increased by 100%, reaching RMB 1,203,563,854.44, attributed to changes in accounting policies[22]. - The company executed a new revenue recognition standard starting January 1, 2020, adjusting the beginning balance of contract liabilities[64]. Other Financial Metrics - The company reported a non-operating income of approximately CNY 10.78 million from various sources[15]. - Tax payable decreased by 48.61% to RMB 44,119,420.11, mainly due to a reduction in taxes payable at the end of the period[22]. - Non-current liabilities due within one year decreased by 46.75% to RMB 82,425,042.11, primarily due to a reduction in long-term borrowings due within one year[22]. - Other income decreased by 34.76% to RMB 2,846,667.45, mainly due to a reduction in government subsidies received[22]. - Investment income dropped by 98.92% to RMB 5,843,973.80, primarily due to a decrease in investment income from equity transfers[22]. - The fair value change income increased by 37.10% to RMB 8,644,486.98, attributed to an increase in the fair value of trading financial assets[22].